Skip to Main Content
Press Releases

Baker Donelson Represents Provectus Biopharmaceuticals in Public Offering

(Nashville, Tennessee / September 10, 2015) The law firm of Baker Donelson represented Knoxville, Tennessee-based Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, in a $13 million public offering of common stock and warrants. Baker Donelson also advised the company in connection with listing the warrants issued in the offering on the NYSE MKT. 

The Baker Donelson team representing Provectus included shareholder Tonya Mitchem Grindon and associates Christopher Douse and Jimmie B. Strong, all from the Firm's Nashville office.

News Contact

Johanna Burkett
T: 901.577.2201
  Email Professional

Related Professionals

Related Practice

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept